NO20005751D0 - Merkede analoger av glutamin og lysin - Google Patents

Merkede analoger av glutamin og lysin

Info

Publication number
NO20005751D0
NO20005751D0 NO20005751A NO20005751A NO20005751D0 NO 20005751 D0 NO20005751 D0 NO 20005751D0 NO 20005751 A NO20005751 A NO 20005751A NO 20005751 A NO20005751 A NO 20005751A NO 20005751 D0 NO20005751 D0 NO 20005751D0
Authority
NO
Norway
Prior art keywords
glutamine
lysine
labeled analogs
peptidases
embolism
Prior art date
Application number
NO20005751A
Other languages
English (en)
Other versions
NO20005751L (no
Inventor
Anthony Eamon Storey
Marivi Mendizabal
Susan Champion
Alex Gibson
Benedicte Guilbert
Ian Andrew Wilson
Peter Knox
Original Assignee
Nycomed Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Amersham Plc filed Critical Nycomed Amersham Plc
Publication of NO20005751D0 publication Critical patent/NO20005751D0/no
Publication of NO20005751L publication Critical patent/NO20005751L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20005751A 1998-05-15 2000-11-14 Merkede analoger av glutamin og lysin NO20005751L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98303872 1998-05-15
PCT/GB1999/001550 WO1999060018A1 (en) 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues

Publications (2)

Publication Number Publication Date
NO20005751D0 true NO20005751D0 (no) 2000-11-14
NO20005751L NO20005751L (no) 2001-01-08

Family

ID=8234827

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005751A NO20005751L (no) 1998-05-15 2000-11-14 Merkede analoger av glutamin og lysin

Country Status (17)

Country Link
US (2) US7049289B1 (no)
EP (1) EP1077998B1 (no)
JP (2) JP4199420B2 (no)
KR (1) KR100660509B1 (no)
CN (2) CN1309661A (no)
AT (1) ATE384075T1 (no)
AU (1) AU762736B2 (no)
BR (1) BR9910468A (no)
CA (1) CA2332277A1 (no)
DE (1) DE69937996T2 (no)
ES (1) ES2299245T3 (no)
HU (1) HUP0102154A3 (no)
IL (1) IL139385A (no)
NO (1) NO20005751L (no)
RU (1) RU2205186C2 (no)
WO (1) WO1999060018A1 (no)
ZA (1) ZA200006313B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239655A1 (en) * 2001-01-05 2002-07-16 Duke University Contrast enhancement agent for magnetic resonance imaging
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
MXPA04000173A (es) * 2001-07-10 2004-03-18 Amersham Health As Compuestos basados en peptidos.
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
GB0224799D0 (en) * 2002-10-25 2002-12-04 Amersham Plc Improved complex compositions
US20070184537A1 (en) * 2003-06-03 2007-08-09 Paul Scherrer Institut Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
ES2663496T3 (es) 2005-11-29 2018-04-13 Nihon Medi-Physics Co., Ltd. Compuesto precursor de compuesto orgánico marcado con halógeno radiactivo
WO2008060368A2 (en) * 2006-10-02 2008-05-22 Duke University Transglutaminase-binding peptides and methods of use
US20130195756A1 (en) * 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
US10610608B2 (en) 2013-08-01 2020-04-07 Rochester Institute Of Technology Modular imaging agents containing amino acids and peptides
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
EP3538093B1 (en) * 2016-11-09 2023-10-25 Qiagen Sciences, LLC Photoprotective mixtures as imaging reagents in sequencing-by-synthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59186947A (ja) * 1983-03-09 1984-10-23 Kowa Co 新規ペプチド
WO1989000051A1 (en) * 1987-07-07 1989-01-12 Cytrx Biopool Ltd. Fibrin-binding compound and method
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
CA2127284C (en) * 1992-01-03 2002-02-05 Buck A. Rhodes Protein- and peptide-metal ion pharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
DE69830057T2 (de) * 1997-01-21 2006-06-29 Ge Healthcare Ltd., Little Chalfont MARKIERTE FAKTOR XIIIa SUBSTRATE

Also Published As

Publication number Publication date
DE69937996T2 (de) 2009-01-02
IL139385A0 (en) 2001-11-25
CN101407543A (zh) 2009-04-15
ATE384075T1 (de) 2008-02-15
RU2205186C2 (ru) 2003-05-27
NO20005751L (no) 2001-01-08
DE69937996D1 (de) 2008-03-06
US20060292075A1 (en) 2006-12-28
JP2002515510A (ja) 2002-05-28
AU762736B2 (en) 2003-07-03
BR9910468A (pt) 2001-01-09
AU3942899A (en) 1999-12-06
EP1077998A1 (en) 2001-02-28
JP2006137751A (ja) 2006-06-01
ES2299245T3 (es) 2008-05-16
WO1999060018A1 (en) 1999-11-25
CA2332277A1 (en) 1999-11-25
EP1077998B1 (en) 2008-01-16
CN1309661A (zh) 2001-08-22
ZA200006313B (en) 2002-07-17
JP4199420B2 (ja) 2008-12-17
KR100660509B1 (ko) 2006-12-22
KR20010043608A (ko) 2001-05-25
IL139385A (en) 2005-09-25
HUP0102154A2 (hu) 2001-09-28
HUP0102154A3 (en) 2009-01-28
US7049289B1 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
NO20005751D0 (no) Merkede analoger av glutamin og lysin
FI932249A (fi) Dubbelverkande inhibitorer
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
PE44895A1 (es) Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero
IT1075527B (it) Procedimento per la determinazione di substrati oppure di attivita' enzimatiche
ATE171068T1 (de) Chinoloncarbonsäurederivate, ihre herstellung und ihre verwendung als zelladhäsion inhibitoren
FI943728A (fi) Enkefalinaasin ja ACE:n inhibiittoreina käyttökelpoisia uusia aminoasetyylimerkaptojohdannaisia
ATE358473T1 (de) Diamino-propanol-verbindungen zur behandlung von ischaemien
BR9908412A (pt) Composição enzimática estabilizada e método para sua preparação
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ES2054480T3 (es) Nuevos sustratos de enzimas, analogos de acidos grasos.
BR0114884A (pt) Compostos calcilìticos
DK431189A (da) Peptidaseinhibitorer
ATE261124T1 (de) Biotin-peg-substrat für einen lipase-assay
ATE280755T1 (de) 3-oxo-1-propansulfonsäure und -sulfonate
IT1264084B1 (it) Peptide ad attivita' di substrato e/o inibitore dell'enzima transglutaminasi e suo uso in diagnosi e terapia.
HU9201474D0 (en) 2-mercaptomethylene-tetrahydro-naphtalyn- and indene-2-carboxamide derivatives with enkephalynase inhibitor effect
HU911038D0 (en) Enzime inhibitors substituted with a halogenethyl group